Previous studies show that translocation and degradation of apolipoprotein B (apoB), two processes occurring on or within the endoplasmic reticulum, determine how much de novo synthesized apoB is secreted. We determined which of these processes regulates the intracellular fate of apoB by examining whether degradation determines how much apoB is translocated or if translocation determines how much apoB is degraded. 35 S]methionine-labeled proteins), its effect on apoB was specific. Pulsechase studies showed that ALLN dramatically reduced the first-order rate of removal of [ 35 S]methionine-labeled apoB from the cell but did not effect its rate of secretion. The finding that ALLN caused the intracellular accumulation of incompletely translated chains of apoB suggests that at least some of the degradation occurs at the ribosomal level. Moreover, 85% of the apoB that accumulated in isolated microsomes in response to ALLN was accessible to exogenous trypsin, indicating this pool of apoB was incompletely translocated. The combined data suggest that translocation, not degradation, determines the intracellular fate of de novo synthesized apoB. apoB 1 is the major structural protein responsible for the assembly of triglyceride-rich lipoproteins by the intestine and liver (1-3). After secretion into blood plasma by the liver, VLDL triglycerides are rapidly hydrolyzed into free fatty acids, which are taken up by peripheral tissues where they are utilized for energy and anabolic purposes. The remaining VLDL remnants, containing apoB100, are then either removed by the liver or converted into LDL, a major risk factor for atherosclerosis (reviewed in Ref. 4). Because of the importance of hepatic secretion of VLDL apoB in determining blood levels of LDL, a major goal of our research has been directed toward identifying the regulatory factors and processes.We have made two observations, both of which have shown unusual characteristics governing the hepatic secretion of apoB: 1) a large amount of de novo synthesized apoB is not secreted but is degraded intracellularly (5) and 2) the translocation of apoB across the endoplasmic reticulum is unusually inefficient (6). These results led us to hypothesize that as a result of incomplete translocation, apoB is diverted from the secretory pathway into a degradative pathway that occurs in the endoplasmic reticulum (3, 6). Regulated translocation of apoB across the endoplasmic reticulum could explain the posttranslational control of apoB secretion. In several studies, the amount of apoB that is secreted is less than the amount that is synthesized (5,(7)(8)(9)(10)(11)(12)(13)(14), leading to the conclusion that the unaccounted for apoB is degraded intracellularly. The consistent observation that in different types of cultured cells and perfused organs obtained from several species, a diverse group of hormones, nutritional states, stimulatory and inhibitory lipids, and mutations in the coding region of apoB alter the rate of apoB secretion by reciprocal changes in its rate of intracellular ...